Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for postoperative sedation in head and neck cancer surgery
2009-013123-33Phase 4Completed
- Sponsor
- Taysha Gene Therapies
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in lip cancer, mouth cancer and head and neck cancer (HNC), sponsored by Taysha Gene Therapies. Started Jun 2009; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
lip cancermouth cancerhead and neck cancer (HNC)
Beyond the preview
Go deeper on 2009-013123-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013123-33.